The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117912292 11791229 2 F 20150121 20160816 20151201 20160824 EXP BR-JNJFOC-20150201616 JANSSEN 51.08 YR A F Y 83.00000 KG 20160824 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117912292 11791229 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U 0 300 MG LYOPHILIZED POWDER
117912292 11791229 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U 0 LYOPHILIZED POWDER
117912292 11791229 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U 0 300 MG LYOPHILIZED POWDER
117912292 11791229 4 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) Y U 103772 LYOPHILIZED POWDER
117912292 11791229 5 SS PREDNISONE. PREDNISONE 1 Unknown Y 0 UNSPECIFIED
117912292 11791229 6 SS PREDNISONE. PREDNISONE 1 Unknown Y 0 20 MG UNSPECIFIED
117912292 11791229 7 SS METHOTREXATE. METHOTREXATE 1 Unknown U 0 UNSPECIFIED
117912292 11791229 8 C ARAVA LEFLUNOMIDE 1 Unknown 0 20 MG UNSPECIFIED
117912292 11791229 9 C OLMETEC OLMESARTAN MEDOXOMIL 1 Unknown 0 UNSPECIFIED
117912292 11791229 10 C FLUXENE FLUOXETINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
117912292 11791229 11 C NORVASC AMLODIPINE BESYLATE 1 Unknown 0 UNSPECIFIED
117912292 11791229 12 C BROMAZEPAM BROMAZEPAM 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117912292 11791229 1 Rheumatoid arthritis
117912292 11791229 2 Rheumatoid arthritis
117912292 11791229 3 Ankylosing spondylitis
117912292 11791229 4 Ankylosing spondylitis
117912292 11791229 5 Product used for unknown indication
117912292 11791229 6 Product used for unknown indication
117912292 11791229 7 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117912292 11791229 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117912292 11791229 Chest pain
117912292 11791229 Eye irritation
117912292 11791229 Feeling hot
117912292 11791229 Gastritis
117912292 11791229 Headache
117912292 11791229 Hypertension
117912292 11791229 Infusion related reaction
117912292 11791229 Keratitis
117912292 11791229 Lactose intolerance
117912292 11791229 Malaise
117912292 11791229 Migraine
117912292 11791229 Myalgia
117912292 11791229 Pain
117912292 11791229 Pharyngitis
117912292 11791229 Polyp
117912292 11791229 Thyroid cyst
117912292 11791229 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117912292 11791229 1 20150120 0
117912292 11791229 2 201509 0
117912292 11791229 3 20150120 0
117912292 11791229 4 201509 0